ATE478890T1 - Homotrimerer, erweiterter globulärer kopf von obg3 und verwendungen davon - Google Patents

Homotrimerer, erweiterter globulärer kopf von obg3 und verwendungen davon

Info

Publication number
ATE478890T1
ATE478890T1 AT03756083T AT03756083T ATE478890T1 AT E478890 T1 ATE478890 T1 AT E478890T1 AT 03756083 T AT03756083 T AT 03756083T AT 03756083 T AT03756083 T AT 03756083T AT E478890 T1 ATE478890 T1 AT E478890T1
Authority
AT
Austria
Prior art keywords
obg3
obesity
homotrimeric
extended
globular head
Prior art date
Application number
AT03756083T
Other languages
English (en)
Inventor
John Lucas
Jiunn-Chern Yeh
Deno Dialynas
Original Assignee
Serono Genetics Inst Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Serono Genetics Inst Sa filed Critical Serono Genetics Inst Sa
Application granted granted Critical
Publication of ATE478890T1 publication Critical patent/ATE478890T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/5759—Products of obesity genes, e.g. leptin, obese (OB), tub, fat

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
AT03756083T 2002-05-31 2003-05-26 Homotrimerer, erweiterter globulärer kopf von obg3 und verwendungen davon ATE478890T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38523802P 2002-05-31 2002-05-31
PCT/IB2003/002223 WO2003102027A1 (en) 2002-05-31 2003-05-26 Homotrimeric extended obg3 globular head and uses thereof

Publications (1)

Publication Number Publication Date
ATE478890T1 true ATE478890T1 (de) 2010-09-15

Family

ID=29712149

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03756083T ATE478890T1 (de) 2002-05-31 2003-05-26 Homotrimerer, erweiterter globulärer kopf von obg3 und verwendungen davon

Country Status (7)

Country Link
US (1) US7459433B2 (de)
EP (1) EP1509545B8 (de)
AT (1) ATE478890T1 (de)
AU (1) AU2003232404A1 (de)
DE (1) DE60333917D1 (de)
ES (1) ES2350573T3 (de)
WO (1) WO2003102027A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8892184B2 (en) 2010-10-18 2014-11-18 Siemens Medical Solutions Usa, Inc. Systems and methods for reducing interference in a dual modality imaging system

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020019346A1 (en) * 1997-05-21 2002-02-14 Children's Medical Center Corporation Treatment of prostate cancer by inhibiting lyn tyrosine kinase
FR2767135B1 (fr) 1997-08-06 2002-07-12 Genset Sa Recepteur complexe lsr, activite, clonage, et application au diagnostic, a la prevention et/ou au traitement de d'obesite et des risques ou complications associes
US7223727B2 (en) 1998-04-09 2007-05-29 Serono Genetics Institute S.A. GSSP4 polynucleotides and polypeptides and uses thereof
US6989367B2 (en) 2000-01-14 2006-01-24 Genset S.A. OBG3 globular head and uses thereof
US6579852B2 (en) 2000-01-14 2003-06-17 Genset S.A. OBG3 globular head and uses thereof for decreasing body mass
DE60135439D1 (de) * 2000-01-14 2008-10-02 Serono Genetics Inst Sa Obg3 globularekopf und seine verwendungen zur reduzierung des körpersgewichtes
US20020058617A1 (en) 2000-01-14 2002-05-16 Joachim Fruebis OBG3 globular head and uses thereof for decreasing body mass
US6566332B2 (en) 2000-01-14 2003-05-20 Genset S.A. OBG3 globular head and uses thereof for decreasing body mass
EP1357973B1 (de) 2001-02-09 2008-08-20 Serono Genetics Institute S.A. Gssp4-polynukleotide und -polypeptide sowie deren verwendung
WO2003010197A2 (en) 2001-07-25 2003-02-06 Genset S.A. Gmg-1 polynucleotides and polypeptides and uses thereof
US6867189B2 (en) 2001-07-26 2005-03-15 Genset S.A. Use of adipsin/complement factor D in the treatment of metabolic related disorders
CA2453653A1 (en) 2001-07-26 2003-02-06 Genset S.A. Gmg-2 polynucleotides and polypeptides and uses thereof
DE60224064T2 (de) 2001-10-05 2008-11-20 Serono Genetics Institute S.A. Fragmente des humanen zn-alpha2-glykoproteins und deren verwendung in methoden zur behandlung der fettleibigkeit
JP2005514010A (ja) 2001-10-12 2005-05-19 セローノ ジェネティクス インスティテュート ソシエテ アノニム Ｎｇｚｉｐａ、ｎｇｚｉｐｄ、ｐｇｚｉｐａおよびｐｇｚｉｐｄポリヌクレオチドおよびポリペプチド、ならびにその使用
WO2003055916A2 (en) 2001-12-21 2003-07-10 Maxygen Aps Adiponectin fragments and conjugates
EP1506229A1 (de) 2002-05-17 2005-02-16 Serono Genetics Institute S.A. Obg3 fragmente, welche die umwandlung von aktivem obg3 in weniger aktives obg3 verhindern und andere zusammensetzungen zur behandlung von stoffwechselerkrankungen

Also Published As

Publication number Publication date
EP1509545A1 (de) 2005-03-02
EP1509545B8 (de) 2010-10-13
DE60333917D1 (de) 2010-10-07
AU2003232404A1 (en) 2003-12-19
EP1509545B1 (de) 2010-08-25
ES2350573T3 (es) 2011-01-25
WO2003102027A1 (en) 2003-12-11
US20060252678A1 (en) 2006-11-09
US7459433B2 (en) 2008-12-02

Similar Documents

Publication Publication Date Title
CY1108461T1 (el) Σφαιρικη κεφαλη του obg3 και χρησεις αυτου για την μειωση της σωματικης μαζας
WO2003010314A3 (en) Gmg-2 polynucleotides and polypeptides and uses thereof
DE60211199D1 (de) 3-substituierte oxindol-beta-3-agonisten
DE60234453D1 (de) Substituierte piperazin- und diazepanderivate zur verwendung als histamin h3 rezeptormodulatoren
ATE348816T1 (de) 2,5-dioxoimidazolidin-4-ylacetamide und analoga als inhibitoren von metalloproteinase mmp12
EA200300944A1 (ru) Ацилированные пиперидиновые производные в качестве агонистов рецептора-4 меланокортина
NO20022318L (no) Nye forbindelser
DE60205465D1 (de) Piperazinderivate als agonisten des melanocortin-rezeptors
BR0208150A (pt) Antagonistas de mch e sua aplicação no tratamento da obesidade
DE60326453D1 (de) Die verwendung von hmgb1 zur behandlung von gewebeverletzungen und/oder zur unterstützung der gewebewiederherstellung
EA200300528A1 (ru) 1-арил-или 1-алкилсульфонилгетероциклилбензазолы в качестве лигандов 5-гидрокситриптамина-6
ATE547430T1 (de) Multimere des cytokinrezeptors zcytor17
EA200500392A1 (ru) Производные пиримидина и их применение в качестве модуляторов св2
EA200301232A1 (ru) Новые соединения арилсульфонамида и их применение для лечения ожирения, диабета типа ii и нарушений центральной нервной системы
SE0100172D0 (sv) New inhibitors against galectins
PL374383A1 (en) Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation
WO2003010197A3 (en) Gmg-1 polynucleotides and polypeptides and uses thereof
DE60206164D1 (de) Trisubstituierte-n-((1s)-1,2,3,4-tetrahydro-1-naphthalenyl) benzamide welche p2x3 und p2x2/3 enthaltende rezeptoren inhibieren
ATE478890T1 (de) Homotrimerer, erweiterter globulärer kopf von obg3 und verwendungen davon
ATE204172T1 (de) Endothelin-rezeptorantagonisten zur bekämpfung von hyperlipidämie
DE602004025458D1 (de) SYNTHESE VON 2-HYDROXY-N,N-DIMETHYL-3-ii2-i1(R)-(5-METHYL-2-FURANYL)PROPYL AMINO -3,4-DIOXO-1-CYCLOBUTEN-1-YL AMINO BENZAMID
EA200500770A1 (ru) Конденсированные гетероциклические соединения
ATE380868T1 (de) Fragmente des humanen zn-alpha2-glykoproteins und deren verwendung in methoden zur behandlung der fettleibigkeit
ATE437949T1 (de) Gpr8 ligand und dafuer kodierende dna
ATE333452T1 (de) 4-(penylpiperidin-4-ylidenmethyl)benzamidderiva e und deren verwendung zur behandlung von schmerzen,angstzuständen oder erkrankungen des magen-darm- trakts

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties